EFCC1: A Promising Drug Target and Biomarker (G79825)

Target Name: EFCC1

NCBI ID: G79825

EFCC1

EFCC1: A Promising Drug Target and Biomarker

EFCC1 (E scintillation calcin), also known as CCDC48, is a protein that is expressed in various tissues throughout the body, including the nervous system, muscle systems, and bones. It is a key regulator of cell-cell interactions and has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

Recent studies have identified EFCC1 as a potential drug target for a variety of therapeutic applications. EFCC1 has been shown to play a role in the development and progression of cancer, including breast, ovarian, and prostate cancers. It has also been linked to the development of neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases. Additionally, EFCC1 has been implicated in autoimmune disorders, such as rheumatoid arthritis and multiple sclerosis.

One of the key reasons for EFCC1's potential as a drug target is its high level of expression in various tissues. This makes it an attractive target for drugs that can modulate its activity and potentially disrupt its function. Additionally, EFCC1's protein structure is well- conserved across various species, which suggests that it is a reliable and robust target for therapeutic intervention.

In addition to its potential as a drug target, EFCC1 is also a biomarker that can be used to diagnose and monitor various diseases. For example, it has been used as a marker for cancer diagnosis, particularly in the detection of breast cancer. Additionally, EFCC1 has been shown to be a reliable biomarker for neurodegenerative diseases, such as Alzheimer's disease, and has been used in the diagnosis and monitoring of multiple sclerosis.

Overall, EFCC1 is a protein that holds great promise as a drug target and biomarker. Its high level of expression in various tissues and its well-conserved protein structure make it an attractive target for therapeutic intervention. Additionally, its potential as a biomarker for a variety of diseases makes it an important tool for the diagnosis and monitoring of these conditions. Further research is needed to fully understand the role of EFCC1 in disease and to develop effective therapies that can modulate its activity.

Protein Name: EF-hand And Coiled-coil Domain Containing 1

The "EFCC1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about EFCC1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets